A nuclear receptor cell-based reporter assay
Features
  • Screen test samples to quantify functional activity, either agonist or antagonist, they may exert against human CHRM1
  • Robust technology provides sustained response for consistent and reproducible data acquisition
  • Included in kit: Ready-to-use, pre-transfected reporter cells | Optimized media | Reference agonist | Luciferase detection reagent | Cell culture ready assay plate
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Human Cholinergic Receptor, Muscarinic 1 Activation Reporter Assay System

Item No. 45428

Product Insert (PDF)
Technical Information
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    This assay utilizes proprietary human cells that have been engineered to provide constitutive expression of the Human Cholinergic receptor, Muscarinic 1 (CHRM1).

    CHRM1 activation of the PLC pathways leads to an increase in intracellular calcium and the concomitant activation of calcineurin, a calcium-dependent phosphatase. Ca+2- calcineurin acts to dephosphorylate and activate the transcription factor NFAT3. CHRM1 activation of the Ca+2∙calcineurin > NFAT cascade is the signal transduction pathway exploited by the reporter cells provided in this kit.

    INDIGO's CHRM1 Reporter Cells contain an engineered luciferase reporter gene functionally linked to tandem consensus sequences of NFAT genetic response elements upstream of a minimal promoter. Activated NFAT binds to these response elements to seed the formation of a complete transcription complex that drives luciferase gene expression. Quantifying relative changes in luciferase activity in the treated reporter cells relative to the untreated reporter cells provides a sensitive surrogate measure of drug-induced changes in CHRM1 activity. Accordingly, the principal application of this reporter assay is in the screening of test compounds to quantify activating functional activities that they may exert against CHRM1, or the coupled Ca+2∙calcineurin / NFAT signal transduction pathway.

    The Reporter Cells in this kit are transiently transfected and prepared as frozen stocks using INDIGO’s proprietary CryoMite™ process. This cryo-preservation method allows for the immediate dispensing of healthy, division-competent reporter cells into assay plates. There is no need for intermediate treatment steps such as spin-and-rinse of cells, viability determinations or cell titer adjustments prior to assay setup.

    INDIGO's assay kits provide the convenience of an all-inclusive cell-based assay system. In addition to CHRM1 Activation Reporter Cells, provided are two optimized media for use in recovering the cryopreserved cells and for diluting test samples, the reference activator Acetylcholine (chloride), Luciferase Detection Reagents, and a cell culture-ready assay plate.protocol. [INDIGO Catalog Nos. IB44001 | IB44001-32]

    WARNING This product is not for human or veterinary use.